Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)

Clinical trial NCT02395172 · COMPLETED

Trial details

NCT number: NCT02395172
Sponsor: EMD Serono Research & Development Institute, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2015-03-24
Primary completion: 2017-11-22
Enrollment: 792

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.